Nutlin‐3 has a synergistic cytotoxic effect when used in combination with TNF‐related apoptosis‐inducing ligand (TRAIL), bortezomib, and cisplatin to induce p53‐dependent tumor cell apoptosis in NSCLC [31, 33]. This evidence concerns the gene TP53 and non-small cell lung carcinoma.